ClinicalTrials.Veeva

Menu

To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke (ULIS2)

Ipsen logo

Ipsen

Status

Completed

Conditions

Muscle Spasticity

Study type

Observational

Funder types

Industry

Identifiers

NCT01020500
Y-79-52120-138

Details and patient eligibility

About

The purpose of the study is to assess the responder rate as defined by the achievement of the primary goal from the Goal Attainment Scale following one BoNT-A injection cycle in accordance with routine practices.

Enrollment

469 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Upper limb spasticity following stroke
  • At least a 12-week interval between the last injection (BoNT-A or BoNT-B) and inclusion
  • Decision already been agreed to inject BoNT-A
  • Agreement with the subject on goal setting

Exclusion criteria

  • Contraindications to any BoNT-A preparations

Trial contacts and locations

96

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems